Results 31 to 40 of about 17,756 (301)
Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report
Journal of Medical Case Reports, 2010 Introduction Ticlopidine is a platelet inhibitor used to prevent thrombosis in patients with cerebrovascular or coronary artery disease. The most common side effects are mild and transitory: diarrhea, dyspepsia, nausea and rashes.
Previtera Antonino M, Pagani Rossella
doaj +1 more source
JMIR Medical Informatics, 2021 BackgroundMedicines may cause various adverse reactions. An enormous amount of money and effort is spent investigating adverse drug events (ADEs) in clinical trials and postmarketing surveillance.
Kei Teramoto +7 more
doaj +1 more source
Cilostazol reduces restenosis after carotid artery stenting [PDF]
, 2010 BACKGROUND: Although carotid artery stenting (CAS) has been proposed as an alternative to carotid endarterectomy in cerebral revascularization, restenosis remains an unsolved issue.
Hayakawa Mikito +6 more
core +1 more source
Pathogens and Disease, 2015 Enterococcus faecalis and Streptococcus gallolyticus cause infective endocarditis (IE), which can originate from the continuous release or translocation of low bacterial numbers into the bloodstream.
T. Veloso +5 more
semanticscholar +1 more source
Study of Factors to Increase the Usage Rate of Generic Drugs in Platelet Aggregation Inhibitors
Inquiry: The Journal of Health Care Organization, Provision, and Financing, 2023 To reduce pharmacy-related medical expenses, it is necessary to reduce drug costs. One way to achieve this is by increasing the usage rate of generic drugs.
Takaaki Suzuki BS +9 more
doaj +1 more source
Pharmacokinetics of Ticlopidine in the Rabbit
Journal of Pharmacy and Pharmacology, 1999 Abstract There is no information about the pharmacokinetics of ticlopidine in rabbits. Such information is valuable in designing appropriate dosing regimens for experimental studies of the drug with ultimate applications in man. The disposition kinetics of ticlopidine at three dose levels were evaluated in three groups of six rabbits ...
Francois Vallee +4 more
openaire +3 more sources
The effect of antiaggregational therapy on the long-term patency of the femoropopliteal/crural bypass [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2012 Introduction. Antiaggregational therapy can reduce thrombosis development following the arterial reconstruction surgery. In most cases acetylsalicylic acid and ticlopidine are used as antiaggregational agents. Objective.
Vasić Dragan +3 more
doaj +1 more source
Drugs for preventing red blood cell dehydration in people with sickle cell disease. [PDF]
, 2016 BACKGROUND: Sickle cell disease is an inherited disorder of hemoglobin, resulting in abnormal red blood cells. These are rigid and may block blood vessels leading to acute painful crises and other complications.
Ballas, Samir K., Nagalla, Srikanth
core +2 more sources
Ticlopidine-induced cholestatic hepatitis: A case report and review of the literature
Italian Journal of Medicine, 2012 Introduction Cholestatic hepatitis is frequently a drug-related syndrome. We describe the case of a 57-year-old man who developed cholestatic hepatitis two months after starting therapy with ticlopidine following a carotid endarterectomy.Materials and ...
Luigi Anastasio +7 more
doaj +1 more source
Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone? [PDF]
, 1999 Patients who have had a transient ischaemic attack or nondisabling ischaemic stroke of presumed arterial origin have an annual risk of death from all vascular causes, non-fatal stroke, or non-fatal myocardial infarction that ranges between 4% and 11%
Algra, A. (Ale) +2 more
core +2 more sources